A substrate envelope approach to examine drug resistance potential of SARS-CoV-2 Mpro
A team of scientists from the United States has recently defined the substrate envelop of the main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is currently available on the bioRxiv* preprint server while awaiting peer review.
Source: news-medical.net